Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011SynergystJanuary 1, 2012 80 Pages - SKU: SYGR6745823 |
| Countries covered: Global Fueled by ageing populations, growing numbers of patent expirations and government cost-cutting measures, the global generic drugs market continues to grow. In 2010, sales of generic drugs worldwide is estimated at almost US$170 billion; a CAGR of 9.7% in last five years. It is well known that key patents of multi-billion dollar brand drugs are set to expire within the next few years. The loss of over 200,000 pharmaceutical jobs over the past three years has been mainly driven by the anticipated loss of revenue from blockbuster drugs that will lose patent protection by 2013. Consistent with trends of the past several years, the next five years are expected to reflect a significant imbalance between new product introductions and patent losses. This is the primary factor limiting global pharmaceutical market growth to the mid-single digits through 2013. The on-going patent expirations will force generic manufacturers to replenish product pipelines with new generic versions to expand markets such as the United States, the world's largest generic drug market, and one of the very few countries worldwide where generics fill more than 50% of prescriptions. Over the next five years, products that currently generate an unprecedented $137 billion in sales are expected to face generic competition. At the same time, new products that will enable innovative approaches for treating patients suffering from diseases such as osteoporosis, respiratory ailments, thrombosis, multiple sclerosis and cancer are not expected to generate the same magnitude of sales as products losing patent protection. Many large multinational companies are beginning to explore the untapped potential of emerging economies, particularly Brazil, Russia, India and China, which are growing at robust double-digit rates because of the economic boom, massive population growth and large number of health care reforms being introduced by the governments. Over the next few years, markets will be impacted by numerous payer actions, including the imposition of price cuts on existing drugs, the raising of standards required to achieve reimbursement of innovative therapies, and the use of economic incentives for prescribers and pharmacists to drive a shift to generic alternatives. Synergyst's "Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011" focuses on the current generics market globally and the impact of patent expirations will have on the market in future. Report Coverage and Highlights
|
More Global Manufacturing, Packaging & Detailing Reports
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by
Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...
The World Market for Over The Counter (OTC) Drugs by
Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and ...
Global Pharmaceuticals & Medicine Manufacturing by
IBISWorld
Global Pharmaceuticals & Medicine Manufacturing This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, ...
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry by
iCD Research
Synopsis
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and ...
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry by
iCD Research
Synopsis
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and ...
See all reports like this >>
Related Markets
Manufacturing, Packaging & Detailing Reports
- Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
- Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Perspective: TAKE Solutions Gives Leading Pharma an Edge in Drug Serialization
- The World Market for Over The Counter (OTC) Drugs

